A new study on glaucoma, a leading cause of irreversible blindness, offers a fresh understanding of how the disease ...

Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, today announced that it has received CE Mark approval under ...

The study by OHSU researchers unlocks potential new treatment options for a leading cause of blindness In a new study, OHSU ...

Canaloplasty is a surgical procedure for glaucoma that targets main structures that channel the outflow of aqueous fluid at the front of the eye, such as the trabecular meshwork, Schlemm’s canal ...

Project: The Genetics of Glaucoma: Lipid nanoparticle-mediated delivery of base editor ribonucleoprotein complex targeting the trabecular meshwork for the treatment of glaucoma To date ...

The new combination therapy offers a dual mechanism of action for superior intraocular pressure (IOP) control: Ripasudil enhances aqueous humour outflow through the trabecular meshwork, while timolol ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.